Published in J Neuropathol Exp Neurol on December 01, 2007
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
Toll-like receptors in neurodegeneration. Brain Res Rev (2008) 2.15
Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci (2009) 1.80
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) (2011) 1.73
Toll-Like Receptors and Dectin-1, a C-Type Lectin Receptor, Trigger Divergent Functions in CNS Macrophages. J Neurosci (2015) 1.42
The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clin Dev Immunol (2013) 1.14
Oligodendrocyte fate after spinal cord injury. Neurotherapeutics (2011) 1.09
Pattern recognition receptors and central nervous system repair. Exp Neurol (2014) 1.02
Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci (2012) 0.94
Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia (2010) 0.94
Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol (2009) 0.91
System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo. Exp Neurol (2011) 0.90
11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan-treated rats. J Nucl Med (2011) 0.88
Inhibition of astroglial NF-κB enhances oligodendrogenesis following spinal cord injury. J Neuroinflammation (2013) 0.87
Inhibitors of myelination: ECM changes, CSPGs and PTPs. Exp Neurol (2013) 0.86
Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury. Neurobiol Dis (2012) 0.85
Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice. J Neuroinflammation (2014) 0.84
Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci (2015) 0.83
Stimulation of adult oligodendrogenesis by myelin-specific T cells. Am J Pathol (2011) 0.83
Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators Inflamm (2013) 0.81
Early proliferation does not prevent the loss of oligodendrocyte progenitor cells during the chronic phase of secondary degeneration in a CNS white matter tract. PLoS One (2013) 0.81
Neuroinflammation: the devil is in the details. J Neurochem (2016) 0.80
Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage. Exp Neurol (2014) 0.79
Inherited and acquired disorders of myelin: The underlying myelin pathology. Exp Neurol (2016) 0.77
IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation. Brain (2016) 0.76
Stress exacerbates neuron loss and microglia proliferation in a rat model of excitotoxic lower motor neuron injury. Brain Behav Immun (2015) 0.76
E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord. Glia (2017) 0.76
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord. J Neurosci (2016) 0.75
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination. Mol Cells (2015) 0.75
Diaphragm Electromyographic Activity following Unilateral Mid-Cervical Contusion Injury in Rats. J Neurophysiol (2016) 0.75
Intraspinal TLR4 activation promotes iron storage but does not protect neurons or oligodendrocytes from progressive iron-mediated damage. Exp Neurol (2017) 0.75
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma (2006) 5.32
Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol (2007) 3.06
Replication and reproducibility in spinal cord injury research. Exp Neurol (2011) 2.31
Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation (2011) 2.02
Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol (2003) 1.94
Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem (2007) 1.92
Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol (2006) 1.84
Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci (2009) 1.80
Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci (2011) 1.59
Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol (2007) 1.52
An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods (2009) 1.48
Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol (2004) 1.47
Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol (2008) 1.46
B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest (2009) 1.37
Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration. Prog Brain Res (2009) 1.35
Inflammation and axon regeneration. Curr Opin Neurol (2011) 1.33
Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci (2002) 1.33
Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia (2007) 1.29
Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J Neurochem (2007) 1.28
Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem (2006) 1.25
Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation (2010) 1.24
Regional heterogeneity in astrocyte responses following contusive spinal cord injury in mice. J Comp Neurol (2010) 1.20
Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav Immun (2009) 1.18
Progranulin expression is upregulated after spinal contusion in mice. Acta Neuropathol (2009) 1.17
Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J Neurosci (2005) 1.16
A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma (2010) 1.13
Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J Neurochem (2009) 1.11
Oligodendrocyte fate after spinal cord injury. Neurotherapeutics (2011) 1.09
Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J Neurosci (2013) 1.07
Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci (2004) 1.07
MICAL flavoprotein monooxygenases: expression during neural development and following spinal cord injuries in the rat. Mol Cell Neurosci (2005) 1.07
B cells and autoantibodies: complex roles in CNS injury. Trends Immunol (2010) 1.05
Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments. J Neurotrauma (2014) 1.05
Semi-automated Sholl analysis for quantifying changes in growth and differentiation of neurons and glia. J Neurosci Methods (2010) 1.05
Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats. J Comp Neurol (2008) 1.03
Silencing Nogo-A promotes functional recovery in demyelinating disease. Ann Neurol (2010) 1.02
A mouse model of ischemic spinal cord injury with delayed paralysis caused by aortic cross-clamping. Anesthesiology (2010) 1.00
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation. J Immunol (2013) 1.00
Macrophage depletion alters the blood-nerve barrier without affecting Schwann cell function after neural injury. J Neurosci Res (2007) 0.98
Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury. Eur J Neurosci (2007) 0.98
Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke (2009) 0.97
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response. J Neuroinflammation (2010) 0.97
Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling. Cell Tissue Res (2012) 0.95
Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci (2012) 0.94
Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury. J Neurosci (2011) 0.93
Toll-like receptors in spinal cord injury. Curr Top Microbiol Immunol (2009) 0.93
Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord. J Comp Neurol (2010) 0.92
Mice lacking L1 cell adhesion molecule have deficits in locomotion and exhibit enhanced corticospinal tract sprouting following mild contusion injury to the spinal cord. Eur J Neurosci (2006) 0.92
Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol (2009) 0.91
Effects of gabapentin on muscle spasticity and both induced as well as spontaneous autonomic dysreflexia after complete spinal cord injury. Front Physiol (2012) 0.90
p53 Regulates the neuronal intrinsic and extrinsic responses affecting the recovery of motor function following spinal cord injury. J Neurosci (2012) 0.90
System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo. Exp Neurol (2011) 0.90
Development of a database for translational spinal cord injury research. J Neurotrauma (2014) 0.90
Debate: "is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol (2006) 0.89
Emerging concepts in myeloid cell biology after spinal cord injury. Neurotherapeutics (2011) 0.89
Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin Ther Targets (2011) 0.89
Inhibition of astroglial NF-κB enhances oligodendrogenesis following spinal cord injury. J Neuroinflammation (2013) 0.87
Microembolism infarcts lead to delayed changes in affective-like behaviors followed by spatial memory impairment. Behav Brain Res (2012) 0.87
Spinal cord injury with unilateral versus bilateral primary hemorrhage--effects of glibenclamide. Exp Neurol (2011) 0.86
Role of induced hypothermia in thoracoabdominal aortic aneurysm surgery. Ther Hypothermia Temp Manag (2012) 0.86
Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Exp Neurol (2012) 0.86
Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice. J Neurotrauma (2014) 0.85
Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity. Clin Immunol (2013) 0.84
Biomaterial design considerations for repairing the injured spinal cord. Crit Rev Biomed Eng (2011) 0.84
Spinal cord injury causes chronic liver pathology in rats. J Neurotrauma (2014) 0.83
Systemic iron chelation results in limited functional and histological recovery after traumatic spinal cord injury in rats. Exp Neurol (2013) 0.83
Neonatal E. coli infection causes neuro-behavioral deficits associated with hypomyelination and neuronal sequestration of iron. J Neurosci (2013) 0.82
The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice. Exp Neurol (2011) 0.80